Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
04/2009
04/30/2009US20090110788 Utilizing motor current variations to control mixer operation
04/30/2009US20090110783 Microwaveable edamame bowl
04/30/2009US20090110691 Ehrlichia canis DIVA (Differentiate Infected from Vaccinated Animals)
04/30/2009US20090110684 Neutralizing monoclonal antibodies to respiratory syncytial virus
04/30/2009US20090110682 Antibody Having Inhibitory Effect on Amyloid Fibril Formation
04/30/2009US20090110670 Drug screening; selecting a lactic acid bacterial strain for administration to a mammal for reducing gastrointestinal inflammation; culturing a Lactobacillus strain, obtaining a cell-free culture supernatant from the strain and evaluating the level of TNF alpha in the supernatant using a model system
04/30/2009US20090110667 Detection and treatment of autoimmune disorders
04/30/2009US20090110659 Immunoglobulin specific to eotaxin for use in diagnosis, prevention and treatment of infections, autoimmune, inflammatory and allergic disorders; chemotactic cytokines designated human eotaxins; selectively modulate leukocyte function
04/30/2009US20090110606 Dispensing apparatus and analyzer
04/30/2009US20090110603 Method For Detecting And Compensating An Underdosage Of Test Strips
04/30/2009US20090110601 Molecularly imprinted polymers for detection in lateral flow devices
04/30/2009US20090110597 Apparatus for Execution of Treatment Operations on Microscope Slides with Tissue Specimens
04/30/2009US20090109422 Detecting element, detecting device and detecting method
04/30/2009US20090107838 Electrochemical carbon monoxide sensor supervision
04/30/2009US20090107758 Method and apparatus for detecting explosives
04/30/2009US20090107217 Method of detecting metal ions by melanin-sensitized piezoelectric sensor
04/30/2009US20090107216 Dual-band micro-planar inverted f antenna used for biomolecular finger print and its identification method
04/30/2009DE202009002663U1 Kit zur Gewinnung und Aufbereitung zellulärer Proben Kit for the extraction and processing of cellular samples
04/30/2009DE202007018799U1 Prüfeinrichtung Test facility
04/30/2009DE102007052518A1 Verfahren zur in vitro-Diagnose und/oder in vitro- Therapieverfolgung von Infektionen A method for in vitro diagnosis and / or in vitro therapy monitoring of infections
04/30/2009DE102007052517A1 ELISPOT-Verfahren mit zwei Filtersystemen ELISPOT method with two filter systems
04/30/2009DE102007049936A1 Verfahren zum Herstellen funktioneller Oberflächenbereiche auf einem Flächensubstrat A method of manufacturing a functional surface areas on a surface of substrate
04/30/2009DE102005063367B4 Chemische Reaktionspatrone und Verfahren zum Betätigen einer chemischen Reaktionspatrone Chemical reaction cartridge and method of operating a chemical reaction cartridge
04/30/2009DE102005051976B4 Kit für hoch-sensitive Nachweisassays Kit for highly sensitive detection assays
04/30/2009CA2817516A1 Multi-chambered tissue containment system for molecular and histology diagnostics
04/30/2009CA2714988A1 Sensor technique for black liquor oxidation control
04/30/2009CA2704126A1 Apparatus and method for electrochemical detection
04/30/2009CA2703947A1 Therapeutic and diagnostic methods using tim-3
04/30/2009CA2703787A1 Antibody directed against pro-gastrin releasing peptide, and use thereof
04/30/2009CA2703741A1 System and method of analyzing fluids at a drilling location
04/30/2009CA2703736A1 Genetic incorporation of 3-aminotyrosine into reductases
04/30/2009CA2703687A1 Microcoil magnetic resonance detectors
04/30/2009CA2703668A1 Synthetic antigenic peptides and lipopeptides derived from mycobacterium avium subsp. paratuberculosis
04/30/2009CA2703631A1 Improved methods and devices for cellular analysis
04/30/2009CA2703390A1 Immunoassay analysis method
04/30/2009CA2703356A1 Method for detection of cancer
04/30/2009CA2703294A1 Method and system for detection of a selected type of molecules in a sample
04/30/2009CA2703184A1 Inhibition of urokinase-type plasminogen activator (upa) activity
04/30/2009CA2703165A1 Biomarkers for prenatal diagnosis of congenital cytomegalovirus
04/30/2009CA2703154A1 Antibodies specific to pro-angiogenic isoforms of vascular endothelial growth factor (vegf)
04/30/2009CA2703140A1 Antibodies against a cancer-associated epitope of variant hnrnpg and uses thereof
04/30/2009CA2703133A1 Antibody-mediated disruption of quorum sensing in bacteria
04/30/2009CA2702984A1 Compositions and methods for treatment of diabetic retinopathy
04/30/2009CA2702938A1 Cancer classification and methods of use
04/30/2009CA2702799A1 Systems and methods for processing sensor data
04/30/2009CA2702790A1 Tissue container for molecular and histology diagnostics incorporating a breakable membrane
04/30/2009CA2702635A1 A new biomarker for monitoring development of diseases and assessing the efficacy of therapies
04/30/2009CA2702623A1 Use of tenascin-w as a biomarker for colon cancer
04/30/2009CA2702510A1 Use of norgestimate as a selective inhibitor of trpc3, trpc6 and trpc7 ion channels
04/30/2009CA2702333A1 Anti-ricin antibody
04/30/2009CA2701945A1 Methods of prognosis
04/30/2009CA2701802A1 Compositions for detecting antibodies to babesia microti and methods of use thereof
04/30/2009CA2701154A1 Test device for platelet aggregation detection
04/30/2009CA2700522A1 Novel hiv targets
04/30/2009CA2700430A1 Influenza virus haemagglutinin-specific monoclonal antibodies
04/30/2009CA2688425A1 Monitoring and compensating for temperature-related error in an electrochemical sensor
04/30/2009CA2685433A1 Downhole spectroscopic hydrogen sulfide detection
04/30/2009CA2608931A1 Molecularly imprinting polymer for extraction of testosterone from water or biological samples
04/30/2009CA2607915A1 New cell models
04/29/2009EP2053632A2 Method of mass spectrometry and a mass spectrometer
04/29/2009EP2053535A2 Automated detection of cell colonies and coverslip detection using hough transforms
04/29/2009EP2053411A1 Component separating device and chemical analysis device using the same
04/29/2009EP2053409A1 Specific markers for metabolic syndrome
04/29/2009EP2053408A2 A procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line
04/29/2009EP2053407A1 The protein serum amyloid P-component (SAP, SAMP) as prognostic and diagnostic marker for the prenatal diagnosis of Trisomy 21 (Down syndrome)
04/29/2009EP2053406A2 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
04/29/2009EP2053405A1 Method for evaluation of stress, stress evaluation apparatus, stress evaluation method, stress evaluation system, stress evaluation program, and recording medium
04/29/2009EP2053404A1 Automated protein analysis kit
04/29/2009EP2053403A2 Affinity fishing for ligands and proteins receptors
04/29/2009EP2053402A1 Fluorescent marker for living organism and fluorescent marking method for the same
04/29/2009EP2053401A1 A method for measuring the biological diversity of a sample
04/29/2009EP2053400A1 Method and system for detection of a selected type of molecules in a sample
04/29/2009EP2053399A1 A chemotaxis essay based on oscillating gradients of chemotactic agents
04/29/2009EP2053398A1 Method for confirming performance of optical detector and reference reagent used for same
04/29/2009EP2053397A1 PPM1E proteins and nucleic acids as targets for neurodegenerative diseases
04/29/2009EP2053396A1 Device and method for the monitoring of the movement of cells
04/29/2009EP2053395A1 Metabolic syndrome evaluation method, metabolic syndrome evaluation apparatus, metabolic syndrome evaluation method, metabolic syndrome evaluation system, metabolic syndrome evaluation program and recording medium, and method for search for prophylactic/ameliorating substance for metabolic syndrome
04/29/2009EP2053394A2 Reagents and method for measuring hydroxyl number in polyols
04/29/2009EP2053393A1 Pladienolide target molecule, compound capable of binding to the target molecule, and screening method for the compound
04/29/2009EP2053387A1 Test device for platelet aggregation detection
04/29/2009EP2053379A1 Method and apparatus for analysis of force traces
04/29/2009EP2053135A1 Bone morphonic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma
04/29/2009EP2053130A1 Method for screening for vitamin d receptor ligand
04/29/2009EP2053129A2 Method of diagnosing, monitoring, staging, imaging and treating various cancers
04/29/2009EP2053126A1 Streptococcus pneumoniae proteins and nucleic acid molecules
04/29/2009EP2053125A1 Streptococcus pyogenes antigens
04/29/2009EP2053063A1 Recognition molecules for treatment and detection of tumours
04/29/2009EP2052739A1 Cancer therapeutic agent comprising ligand for neuromedin u receptor 2 (fm4) molecule as active ingredient
04/29/2009EP2052737A1 Synthetic antigenic peptides and lipopeptides derived from mycobacterium avium subsp. paratuberculosis
04/29/2009EP2052724A1 Use of norgestimate as a selective inhibitor of TRPC3, TRPC6 and TRPC6 and TRPC7 ion channel
04/29/2009EP2052272A2 A magnet system for biosensors
04/29/2009EP2052259A2 Systems and methods for measuring fluid properties
04/29/2009EP2052257A1 Methods and kits for selecting an analgesic regime
04/29/2009EP2052256A1 The use of bnp-type peptides for the stratification of therapy with erythropoietic stimulating agents
04/29/2009EP2052255A2 Methods of determining levels of free amino acids and dipeptides and diagnosing alzheimer's diseases
04/29/2009EP2052254A2 Biomarkers for inflammation of the liver
04/29/2009EP2052253A2 Immunogenic compounds and protein mimics
04/29/2009EP2052252A1 Luminescent lanthanide labelling reagents and their use
04/29/2009EP2052251A1 Combination 5-ht7 receptor antagonist and serotonin reuptake inhibitor therapy
04/29/2009EP2052250A1 Solid-phase detection of terminal monosaccharides cleaved from glycosylated substrates